Cargando…
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
Context: It has been reported that isoprostanes (IPs) have a role in the pathophysiology of ductus arteriosus during the fetal and neonatal period. Our aim in this study was to assess if urinary IPs (uIPs) levels correlate with the risk of developing a hemodynamically significant patent ductus arter...
Autores principales: | Coviello, Caterina, Tataranno, Maria Luisa, Corsini, Iuri, Leonardi, Valentina, Longini, Mariangela, Bazzini, Francesco, Buonocore, Giuseppe, Dani, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506157/ https://www.ncbi.nlm.nih.gov/pubmed/33014939 http://dx.doi.org/10.3389/fped.2020.00555 |
Ejemplares similares
-
Isoprostanes as Biomarker for White Matter Injury in Extremely Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2021) -
Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017) -
Editorial: Management of Patent Ductus Arteriosus in Preterm Infants
por: Atasay, Begüm, et al.
Publicado: (2021) -
Multiscale Modeling Is Required for the Patent Ductus Arteriosus in Preterm Infants
por: Ho, Harvey, et al.
Publicado: (2022) -
Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants
por: Sallmon, Hannes, et al.
Publicado: (2021)